Skip to main content
logo
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.440
+0.120 (3.61%)
At close: Jan 2, 2026, 4:00 PM EST
3.360
-0.080 (-2.33%)
After-hours: Jan 2, 2026, 6:48 PM EST

Q32 Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---6.656.65-
Cost of Revenue
26.3948.1431.7335.8129.93
Gross Profit
-26.39-48.14-38.38-29.16-29.93
Selling, General & Admin
17.1217.969.8810.066.76
Operating Expenses
17.1217.969.8810.066.76
Operating Income
-43.5-66.1-48.26-39.23-36.69
Interest Expense
-1.5-1.4-2--
Interest & Investment Income
2.73.9---
Earnings From Equity Investments
--1.63---
Other Non Operating Income (Expenses)
-14.992.33.02-3.52-0.32
EBT Excluding Unusual Items
-57.29-62.93-47.23-42.75-37.02
Gain (Loss) on Sale of Investments
-0.68-0.68---
Other Unusual Items
15.8915.89-6.19--
Pretax Income
-42.08-47.71-53.43-42.75-37.02
Income Tax Expense
0.020.020.320.060.55
Net Income
-42.1-47.73-53.74-42.81-37.56
Net Income to Common
-42.1-47.73-53.74-42.81-37.56
Shares Outstanding (Basic)
129076
Shares Outstanding (Diluted)
1210076
Shares Change (YoY)
92.00%2666.77%-95.03%8.57%-
EPS (Basic)
-3.45-5.12-153.96-6.09-5.81
EPS (Diluted)
-3.45-6.58-153.96-6.09-5.81
Free Cash Flow
-38.79-67.79-18.68-13.44-33.14
Free Cash Flow Per Share
-3.18-7.02-53.52-1.91-5.12
Operating Margin
----589.76%-
Profit Margin
----643.65%-
Free Cash Flow Margin
----202.10%-
EBITDA
-43.08-65.62-47.76-38.86-36.65
D&A For EBITDA
0.420.490.50.370.05
EBIT
-43.5-66.1-48.26-39.23-36.69
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q